UGT1A9 and viral infectious disease: Similarly, a higher plasma exposure (~70%) to the immunosuppressive mycophenolate mofetil [44,45] (primarily metabolized by hepatic UGT1A9) was observed in transplanted patients with a cytomegalovirus infection, an inflammatory viral disease [46].